Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
viernes, octubre 23
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Microbot Medical Inc
MBOT
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.9419
0.0018
0.19%
Últ. Act.: Oct 23, 2:51 AM
$0.9400
-0.0001
-0.01%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Privacy Manager
Microbot Medical Financials
Microbot Medical (MBOT) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The
Benzinga Newsdesk
PRO
Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 78.95 percent increase over losses of $(0.19) per share from
Benzinga Newsdesk
PRO
Microbot Medical Q2 EPS $(0.10) Misses $(0.08) Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 25 percent. This is a 41.18 percent increase over losses of $(0.17) per share from
Benzinga Newsdesk
Microbot Medical Gets Quality Certification for its System
Microbot Medical Inc. (NASDAQ: MBOT) recently announced the receipt of ISO 13485:2016 certification for its quality management system.
Zacks
Dow Dips Over 300 Points; GameStop Shares Spike Higher
Avi Kapoor
Crude Oil Down Over 3%; US Construction Spending Falls In May
Avi Kapoor
